AAAAAA

   
Results: 1-25 | 26-36 |
Results: 26-36/36
TREATMENT OF OSTEOPOROSIS WITH BISPHOSPHONATES
Authors: WATTS NB
Citation: Nb. Watts, TREATMENT OF OSTEOPOROSIS WITH BISPHOSPHONATES, Rheumatic diseases clinics of North America, 20(3), 1994, pp. 717-734
ENDOCRINOLOGY
Authors: WATTS NB BLEVINS LS
Citation: Nb. Watts et Ls. Blevins, ENDOCRINOLOGY, JAMA, the journal of the American Medical Association, 271(21), 1994, pp. 1666-1668
OSTEOPOROSIS - METHODS TO PREVENT FRACTURES IN PATIENTS AT HIGH-RISK
Authors: WATTS NB
Citation: Nb. Watts, OSTEOPOROSIS - METHODS TO PREVENT FRACTURES IN PATIENTS AT HIGH-RISK, Postgraduate medicine, 95(5), 1994, pp. 73
BONE HISTOMORPHOMETRIC CHANGES AFTER CYCLIC THERAPY WITH PHOSPHATE AND ETIDRONATE DISODIUM IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
Authors: OTT SM WOODSON GC HUFFER WE MILLER PD WATTS NB
Citation: Sm. Ott et al., BONE HISTOMORPHOMETRIC CHANGES AFTER CYCLIC THERAPY WITH PHOSPHATE AND ETIDRONATE DISODIUM IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS, The Journal of clinical endocrinology and metabolism, 78(4), 1994, pp. 968-972
CLINICAL UTILITY OF BEDSIDE MEASUREMENT OF BETA-HYDROXYBUTYRATE IN THE MANAGEMENT OF DIABETIC-KETOACIDOSIS
Authors: UMPIERREZ GE WATTS NB MIXON PS PHILLIPS LS
Citation: Ge. Umpierrez et al., CLINICAL UTILITY OF BEDSIDE MEASUREMENT OF BETA-HYDROXYBUTYRATE IN THE MANAGEMENT OF DIABETIC-KETOACIDOSIS, Clinical research, 42(2), 1994, pp. 10000117-10000117
EFFECTS OF 2 YEARS FOLLOW-UP CYCLICAL ETIDRONATE TREATMENT IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN
Authors: LICATA AA CHESNUT CH GENANT HK HARRIS ST JACKSON RD MILLER PD ROSS PD WASNICH RD WATTS NB
Citation: Aa. Licata et al., EFFECTS OF 2 YEARS FOLLOW-UP CYCLICAL ETIDRONATE TREATMENT IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN, Journal of bone and mineral research, 8, 1993, pp. 190000141-190000141
CALCITONIN TREATMENT OF OSTEOPOROSIS - ANALGESIC RESPONSE AND SIDE-EFFECTS IN CLINICAL-PRACTICE
Authors: WATTS NB WUORIO S
Citation: Nb. Watts et S. Wuorio, CALCITONIN TREATMENT OF OSTEOPOROSIS - ANALGESIC RESPONSE AND SIDE-EFFECTS IN CLINICAL-PRACTICE, Journal of bone and mineral research, 8, 1993, pp. 190000334-190000334
SCREENING FOR DIABETIC NEPHROPATHY - A SYSTEMATIC-APPROACH IN DIABETIC OUTPATIENTS
Authors: WATTS NB RICHARD M GEBHART SSP ELKEBBI I MUSEY V ROBERTSON D
Citation: Nb. Watts et al., SCREENING FOR DIABETIC NEPHROPATHY - A SYSTEMATIC-APPROACH IN DIABETIC OUTPATIENTS, Diabetes, 42, 1993, pp. 190-190
BETA-HYDROXYBUTYRATE AND ACETOACETATE LEVELS - CLINICAL UTILITY IN THE MANAGEMENT OF DIABETIC-KETOACIDOSIS
Authors: UMPIERREZ GE WATTS NB MIXON PS PHILLIPS LS
Citation: Ge. Umpierrez et al., BETA-HYDROXYBUTYRATE AND ACETOACETATE LEVELS - CLINICAL UTILITY IN THE MANAGEMENT OF DIABETIC-KETOACIDOSIS, Clinical research, 41(4), 1993, pp. 10000787-10000787
BEDSIDE MONITORING OF BLOOD-GLUCOSE IN HOSPITALS - SPEED VS PRECISIONAND ACCURACY
Authors: WATTS NB
Citation: Nb. Watts, BEDSIDE MONITORING OF BLOOD-GLUCOSE IN HOSPITALS - SPEED VS PRECISIONAND ACCURACY, Archives of pathology and laboratory medicine, 117(11), 1993, pp. 1078-1079
4-YEAR STUDY OF INTERMITTENT CYCLIC ETIDRONATE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 3 YEARS OF BLINDED THERAPY FOLLOWED BY ONE-YEAR OF OPEN THERAPY
Authors: HARRIS ST WATTS NB JACKSON RD GENANT HK WASNICH RD ROSS P MILLER PD LICATA AA CHESNUT CH
Citation: St. Harris et al., 4-YEAR STUDY OF INTERMITTENT CYCLIC ETIDRONATE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 3 YEARS OF BLINDED THERAPY FOLLOWED BY ONE-YEAR OF OPEN THERAPY, The American journal of medicine, 95(6), 1993, pp. 557-567
Risultati: 1-25 | 26-36 |